Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole (Q81166817)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

Espen Molden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

4

Helge Refsum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Magnhild Hendset

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Monica Hermann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Hilde Lunde

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

9 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

1147-1151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17828532%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-007-0373-6

6 January 2020

exact match

0 references

cites work

Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone

1 reference

12 December 2020

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

12 December 2020

Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram).

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

Safety of aripiprazole: high serum levels in a CYP2D6 mutated patient

1 reference

12 December 2020

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

1 reference

12 December 2020

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

12 December 2020

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

12 December 2020

Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.

1 reference

12 December 2020

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.

1 reference

12 December 2020

Aripiprazole possibly worsens psychosis

1 reference

12 December 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs

1 reference

12 December 2020

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

1 reference

12 December 2020

Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.

1 reference

12 December 2020

The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation

1 reference

12 December 2020